Provided by Tiger Fintech (Singapore) Pte. Ltd.

ReShape Lifesciences, Inc.

2.52
-0.5900-18.97%
Post-market: 2.520.00000.00%19:58 EDT
Volume:1.24M
Turnover:3.21M
Market Cap:6.01M
PE:-0.01
High:2.74
Open:2.69
Low:2.41
Close:3.11
Loading ...

ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for Its Next-Generation Lap-Band® 2.0 Flex

THOMSON REUTERS
·
25 Feb

ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEX

GlobeNewswire
·
25 Feb

BUZZ-ReShape Lifesciences slumps after $6 mln public offering

Reuters
·
18 Feb

BRIEF-Reshape Lifesciences Says Pricing Of Upsized $6.0 Million Public Offering

Reuters
·
16 Feb

ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering

THOMSON REUTERS
·
16 Feb

ReShape Lifesciences Inc - Prices Public Offering of 2,575,107 Units at $2.33 per Unit

THOMSON REUTERS
·
16 Feb

ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering

GlobeNewswire
·
16 Feb

ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology

GlobeNewswire
·
03 Feb

ReShape Lifesciences: in Process of Responding to Comments From SEC Regarding Agreement With Vyome

THOMSON REUTERS
·
13 Jan

ReShape Lifesciences® Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys

THOMSON REUTERS
·
13 Jan

Press Release: ReShape Lifesciences(R) Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys

Dow Jones
·
13 Jan

ReShape Lifesciences Inc Files for Offering of up to 2.1 Mln Shares of Common Stock by Selling Stockholder - SEC Filing

THOMSON REUTERS
·
20 Dec 2024